dc.contributor.author | Vikas | |
dc.contributor.author | Viswanadh, M.K. | |
dc.contributor.author | Priya, V. | |
dc.contributor.author | Mehata, A.K. | |
dc.contributor.author | Muthus, M.S. | |
dc.date.accessioned | 2021-01-07T05:26:33Z | |
dc.date.available | 2021-01-07T05:26:33Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 20415990 | |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1243 | |
dc.language.iso | en_US | en_US |
dc.publisher | Future Medicine Ltd. | en_US |
dc.relation.ispartofseries | Therapeutic Delivery;Vol. 11, Issue 1 | |
dc.subject | cancer | en_US |
dc.subject | long circulation | en_US |
dc.subject | micelle | en_US |
dc.subject | nanotechnology | en_US |
dc.subject | passive targeting | en_US |
dc.subject | Taxotere | en_US |
dc.subject | Tween-80 | en_US |
dc.title | What are the unexplored facts about nanomicelles formed from docetaxel clinical injection? | en_US |
dc.type | Article | en_US |